Nilai Buku saben Saham: Entrada Therapeutics (TRDA)

The development of treatments for brain and nerve pathologies is independent of GDP phases and seasonal fluctuations, demonstrating resilience to crises. This chart illustrates the market value of Entrada Therapeutics (TRDA), which currently stands at 5.99, confirming the potential of a company with a unique IT-based delivery system and patent protection. The success of the therapy here is based on the flawless organization of drug transport into cells.

Entrada Therapeutics Inc. (TRDA): Nilai Buku Saham saka 04.07.2022 nganti 27.10.2026

entradatx.com - rincian analitis lan metrik utama (TRDA)

- rega lan prakiraan konsensus rega:

Rega saham Entrada|TRDA - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Kapitalisasi pasar Entrada Therapeutics, Inc.|TRDA - Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Entrada Therapeutics|TRDA - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku entradatx.com|TRDA - Nilai Agregat Aset

- data utang lan likuiditas:

Total Utang marang Modal Entrada Therapeutics|TRDA - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Entrada Therapeutics, Inc.|TRDA - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Entrada Therapeutics, Inc.

Pambiji fundamental perusahaan:Entrada - TRDA

Produk sing diprodhuksi Entrada Therapeutics, Inc.

The universal delivery platform of Entrada Therapeutics (TRDA) ensures high scalability in drug development, which directly impacts the accumulation of net assets. By analyzing the book value per share chart, an investor assesses the real value of the ownership stake net of liabilities, utilizing this indicator as a defensive filter to determine a fair premium when acquiring the asset.

Pesaing Entrada Therapeutics (TRDA)